{"id":3459,"date":"2021-07-30T15:48:41","date_gmt":"2021-07-30T15:48:41","guid":{"rendered":"http:\/\/inevitablecompany.es\/?p=3459"},"modified":"2021-08-24T19:22:16","modified_gmt":"2021-08-24T19:22:16","slug":"support-communities-involved-in-disease-studies","status":"publish","type":"post","link":"https:\/\/factor-h.org\/pt\/support-communities-involved-in-disease-studies","title":{"rendered":"Apoiar as comunidades envolvidas na doen\u00e7a de estudos"},"content":{"rendered":"<h5 class=\"wp-block-heading\"><strong>A falta de ajuda cont\u00ednua para as fam\u00edlias pobres envolvidas na pesquisa da doen\u00e7a de Huntington semeou ressentimento e desconfian\u00e7a, diz Ignacio Mu\u00f1oz-Sanjuan.<\/strong><\/h5>\n\n\n\n<p>Por Ignacio Mu\u00f1oz-Sanjuan<\/p>\n\n\n\n<p>Ap\u00f3s d\u00e9cadas de pesquisa, uma terapia gen\u00e9tica para a doen\u00e7a de Huntington est\u00e1 sendo testada em ensaios cl\u00ednicos. Patrocinado pela empresa farmac\u00eautica su\u00ed\u00e7a Roche e pela Ionis Pharmaceuticals, com sede nos Estados Unidos, este ensaio tem como alvo o gene que causa a doen\u00e7a. Se o novo tratamento funcionar, poder\u00e1 oferecer uma maneira de interromper a progress\u00e3o dessa doen\u00e7a gen\u00e9tica \u2013 um terr\u00edvel dist\u00farbio neurodegenerativo que ataca principalmente o c\u00e9rebro. A doen\u00e7a de Huntington \u00e9 causada por uma \u00fanica muta\u00e7\u00e3o gen\u00e9tica transmitida de forma dominante, de modo que uma crian\u00e7a tem 50% de chance de herdar a doen\u00e7a se um de seus pais for portador de uma \u00fanica c\u00f3pia do gene defeituoso. <a href=\"http:\/\/inevitablecompany.es\/wp-content\/uploads\/2021\/07\/Nature_IMS_531141a.pdf\" data-type=\"URL\" data-id=\"http:\/\/inevitablecompany.es\/wp-content\/uploads\/2021\/07\/Nature_IMS_531141a.pdf\">CONTINUE LENDO.<\/a><\/p>\n\n\n\n<p>FUENTE: Revista Natureza<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Lack of continued help for poor families involved in Huntington\u2019s-disease research has sown resentment and mistrust, says Ignacio Mu\u00f1oz-Sanjuan. By Ignacio Mu\u00f1oz-Sanjuan After decades of research, a genetic therapy for Huntington\u2019s disease is being tested in clinical trials. Sponsored by Swiss pharmaceutical firm Roche and US-based Ionis Pharmaceuticals, this trial targets the gene that causes [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5097,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[98,41],"tags":[],"class_list":["post-3459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-in-the-press","category-us"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/posts\/3459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/comments?post=3459"}],"version-history":[{"count":0,"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/posts\/3459\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/media\/5097"}],"wp:attachment":[{"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/media?parent=3459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/categories?post=3459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/factor-h.org\/pt\/wp-json\/wp\/v2\/tags?post=3459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}